Pre-transjugular-intrahepatic-portosystemic-shunt measurement of hepatic venous pressure gradient and its clinical application: A comparison study

Figure 7 Changes in the model for end-stage liver disease scores after therapy at baseline, 1-year follow-up, 2-year follow-up and the endpoint of follow-up. A: Patients received endoscopy therapy + non-selective β-blockers (NSBBs); B: Patients received covered transjugular intrahepatic portosystemic shunt (TIPS); C: Patients received endoscopy therapy + NSBBs in the low-hepatic venous pressure gradient (HVPG) tier; D: Patients received covered TIPS in the low-HVPG tier; E: Patients received endoscopy therapy + NSBBs in the high-HVPG tier; F: Patients received covered TIPS in the high-HVPG tier.